These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9842954)

  • 1. Cardiac actions of erythromycin: influence of female sex.
    Drici MD; Knollmann BC; Wang WX; Woosley RL
    JAMA; 1998 Nov; 280(20):1774-6. PubMed ID: 9842954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence.
    Ebert SN; Liu XK; Woosley RL
    J Womens Health; 1998 Jun; 7(5):547-57. PubMed ID: 9650155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heart.
    Drici MD; Ebert SN; Wang WX; Rodriguez I; Liu XK; Whitfield BH; Woosley RL
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):82-8. PubMed ID: 10413072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C; Sterneberg M; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
    Europace; 2018 Oct; 20(10):1699-1706. PubMed ID: 29377987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of magnesium on the electrophysiological effects of erythromycin in the isolated Guinea pig heart.
    Lueger A; Brodmann M; Scherr D; Stark G
    Cardiovasc Drugs Ther; 2002 Jul; 16(4):327-33. PubMed ID: 12652102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
    Frommeyer G; Garthmann J; Ellermann C; Dechering DG; Kochhäuser S; Reinke F; Köbe J; Wasmer K; Eckardt L
    Europace; 2018 Aug; 20(8):1375-1381. PubMed ID: 29016765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible risk for cardiac arrhythmia related to intravenous erythromycin.
    Haefeli WE; Schoenenberger RA; Weiss P; Ritz R
    Intensive Care Med; 1992; 18(8):469-73. PubMed ID: 1289371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
    Brandriss MW; Richardson WS; Barold SS
    Clin Infect Dis; 1994 Jun; 18(6):995-8. PubMed ID: 8086567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
    Eur J Pharmacol; 2007 Dec; 577(1-3):222-32. PubMed ID: 18074444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
    Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
    Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
    Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiological study of pro-arrhythmogenic effects of erythromycin].
    Ponsonnaille J; Citron B; Richard A; Trolese JF; Chaperon A; Barret B; Gras H
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1001-8. PubMed ID: 3144248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender and seasonally related differences in myocardial recovery and susceptibility to sotalol-induced arrhythmias in isolated rabbit hearts.
    Spear JF; Moore EN
    J Cardiovasc Electrophysiol; 2000 Aug; 11(8):880-7. PubMed ID: 10969750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
    Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.
    Frommeyer G; Fischer C; Ellermann C; Dechering DG; Kochhäuser S; Lange PS; Wasmer K; Fehr M; Eckardt L
    Cardiovasc Toxicol; 2018 Feb; 18(1):84-90. PubMed ID: 28612303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.